ExodusPoint Capital Management’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-131,979
Closed -$888K 2659
2022
Q1
$888K Buy
+131,979
New +$1.13M 0.01% 1229
2021
Q2
Sell
-68,682
Closed -$970K 2966
2021
Q1
$970K Buy
68,682
+4,551
+7% +$62.7K 0.01% 929
2020
Q4
$684K Buy
64,131
+47,923
+296% +$435K 0.01% 1064
2020
Q3
$124K Sell
16,208
-7,046
-30% -$51.8K ﹤0.01% 1566
2020
Q2
$141K Buy
23,254
+12,419
+115% +$61.3K ﹤0.01% 1587
2020
Q1
$38K Buy
+10,835
New +$91.8K ﹤0.01% 983

Other funds holding DBD

ExodusPoint Capital Management's DBD Position: Q2 2022 in Review

ExodusPoint Capital Management sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2022, closing a stake of 131,979 shares — an estimated $888K sold.

ExodusPoint Capital Management first reported a position in DBD in Q1 2020 and held it in 6 quarters. The position peaked at $970K in Q1 2021. 169 funds tracked by Wall St. Rank hold DBD as of Q2 2022.

  • ExodusPoint Capital Management reported no remaining Diebold Nixdorf Incorporated position as of Q2 2022 after selling out during the quarter.
  • ExodusPoint Capital Management sold 131,979 Diebold Nixdorf Incorporated shares in Q2 2022, an estimated $888K.
  • ExodusPoint Capital Management first reported a position in Diebold Nixdorf Incorporated in Q1 2020 and held it in 6 quarters.
  • ExodusPoint Capital Management's Diebold Nixdorf Incorporated position peaked at $970K in Q1 2021.
  • 169 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2022.

Based on ExodusPoint Capital Management's 13F filing for Q2 2022, filed 22 Aug 2022.